Q4 Drama Unfolds: Anupam Rasayan’s Sales Climb, Profits Slide—Industry at a Crossroads

Anupam Rasayan India Ltd, a prominent player in the specialty chemicals sector, reported its consolidated financial results for the March 2025 quarter, revealing a mixed performance as industry challenges persist.

 

Key Highlights:

 

Revenue Growth: The company posted consolidated revenue from operations of ₹5,057 million (₹505.7 crore) for Q4FY25, marking a robust 22% year-on-year increase. This recovery comes after a period of subdued sales and highlights a positive shift in demand.

 

Profit Decline: Despite the revenue uptick, consolidated net profit for the quarter stood at ₹445.7 million (₹44.57 crore), reflecting a significant 44% drop compared to ₹726 million in the same quarter last year. This decline is attributed to ongoing industry headwinds and softer sales in key segments.

 

Margin Stability: The company managed to sustain its operating margins at 27% for the full year, demonstrating resilience amid a challenging business environment.

 

Management Outlook: Managing Director Anand Desai acknowledged the persistent difficulties facing the specialty chemicals industry but expressed optimism for FY26, citing a strategic focus on the polymer and pharmaceutical sectors as drivers for future growth.

 

Annual Performance: For the full fiscal year, Anupam Rasayan reported a 4% decline in revenue and a 23% drop in net profit, underscoring the impact of global market volatility and input cost pressures.

 

Market Reaction: Shares of Anupam Rasayan closed marginally lower following the announcement, reflecting cautious investor sentiment amid the profit contraction.

 

Sources: CNBC TV18, Screener, Moneycontrol